Hosted on MSN6mon
New studies reveal underrepresentation of women and Hispanic population in the treatment of peripheral artery disease
Despite an uptick in recent research associated with PAD diagnosis and treatment, 41.2% of clinical trial participants are women and 11% identify as Hispanic—creating a gap in evidence-based ...
MassDevice14d
Philips launches PAD treatment device trial with first successful patient procedure
Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.
MassDevice12d
Endologix reports positive 3-year Detour PAD treatment data
Endologix announced final 36-month results for the DETOUR2 study evaluating its Detour system for treating peripheral ...
Daily3d
Early Antihypertensive Treatment may increase Death risk among Stroke Patients with PAD: CATIS-2 Trial Analysis
China: A recent secondary analysis of the CATIS-2 randomized clinical trial has revealed that early initiation of ...
Optics6d
Philips begins US clinical trial for dual laser-based PAD therapy
Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...
GlobalData on MSN14d
R3 Vascular secures investigational device exemption for PAD treatment
The company has announced that its new investigational device exemption will be used to launch a pivotal trial of its ...
Yahoo Finance14d
R3 Vascular secures investigational device exemption for PAD treatment
Elsewhere in the market of PAD treatment, AngioDynamics has secured a European CE mark for the Auryon Atherectomy System, a laser technology used for the treatment of peripheral artery disease (PAD).